REQUEST A DEMO
Total
USD $0.00
Search more companies

Tamin Pharmaceutical Investment Company Public Joint Stock (Iran)

Main Activities: Pharmaceutical and Medicine Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Tamin Pharmaceutical Investment Company Public Joint Stock Profile Updated: March 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Tamin Pharmaceutical Investment Company (TPICO) was established in 2003 in order to strategically manage the pharmaceutical companies belonging to the Social Security Investment Company (SHASTA). It is one of the biggest pharmaceutical groups regionally in terms of finished production and distribution. The company is responsible for the management of 30 pharmaceutical Iranian companies with combined workforce of 8000 people. Tamin subsidiaries produce over 700 pharma products in 32 therapeutic groups, designated to both local and international markets.

Headquarters
Valie Asr St, No.81- West Nahid St. - Opposite To Mellat Park
Tehran; Tehran; Postal Code: 1966913481

Contact Details: Purchase the Tamin Pharmaceutical Investment Company Public Joint Stock report to view the information.

Website: http://www.tpicoholding.com

Basic Information
Total Employees:
Purchase the Tamin Pharmaceutical Investment Company Public Joint Stock report to view the information.
Outstanding Shares:
Purchase the Tamin Pharmaceutical Investment Company Public Joint Stock report to view the information.
Financial Auditors:
Purchase the Tamin Pharmaceutical Investment Company Public Joint Stock report to view the information.
Incorporation Date:
2003
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
14.58%
Purchase this report to view the information.
6.74%
Purchase this report to view the information.
3.45%
Subsidiaries
Antibayotic
100%
Awzan
100%
Frayend Gostar Suppliy
100%
Company Performance
Financial values in the chart are available after Tamin Pharmaceutical Investment Company Public Joint Stock report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-55.68%
Net Profit (Loss) for the Period
N/A
Total assets
73.21%
Total equity
36.38%
Return on Equity (ROE)
N/A
Quick Ratio
0.01%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?